History of drug resistance or virological failure warrants caution when switching to dolutegravir plus lamivudine
New cases of multi-drug resistant HIV becoming rarer in Europe
Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions
PrEP failures in African programmes are rare, but some are happening in people with good adherence
Injectable HIV therapy should only be given after a check for innate resistance, French study suggests
Top 5 stories on HIV treatment and care in Africa from CROI 2021
Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda
Antibiotics to prevent STIs – for or against?
Molecular HIV surveillance: friend or foe?
